Human cathepsin F: expression in baculovirus system, characterization and inhibition by protein inhibitors

Abstract Recombinant full-length human procathepsin F, produced in the baculovirus expression system, was partially processed during the purification procedure to a form lacking the N-terminal cystatin-like domain and activated with pepsin. Active cathepsin F efficiently hydrolyzed Z-FR-MCA (k/K=106 mM[-1]s[-1]) and Bz FVR-MCA (k/K=8 mM[-1]s[-1]), whereas hydrolysis of Z-RR- MCA was very slow (k/K<0.2 mM[-1]s[-1]). Cathepsin F was rapidly and tightly inhibited by cystatin C, chicken cystatin and equistatin with K values in the subnanomolar range (0.03-0.47 nM), whereas Lkininogen was a less strong inhibitor of the enzyme (K=4.7 nM). Stefin A inhibited cathepsin F slowly (k=1.610exp5 mM[-1]s[-1]) and with a lower affinity (K=25 nM). These data suggest that cathepsin F differs from other related endopeptidases by considerably weaker inhibition by stefins.

[1]  Q. Deveraux,et al.  Comprehensive search for cysteine cathepsins in the human genome , 2004, Biological chemistry.

[2]  D. Brömme,et al.  Production and activation of recombinant papain-like cysteine proteases. , 2004, Methods.

[3]  O. Vasiljeva,et al.  Recombinant human cathepsin H lacking the mini chain is an endopeptidase. , 2003, Biochemistry.

[4]  A. Erickson,et al.  Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L. , 2003, European journal of biochemistry.

[5]  J. R. Somoza,et al.  Expression, purification, crystallization and preliminary X-ray diffraction studies of human cathepsin F complexed with an irreversible vinyl sulfone inhibitor. , 2002, Acta crystallographica. Section D, Biological crystallography.

[6]  J. R. Somoza,et al.  The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators. , 2002, Journal of molecular biology.

[7]  J. Cregg,et al.  Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. , 2002, Current opinion in biotechnology.

[8]  G. Salvesen,et al.  Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. , 2002, Current pharmaceutical design.

[9]  H. Ploegh,et al.  Role for Cathepsin F in Invariant Chain Processing and Major Histocompatibility Complex Class II Peptide Loading by Macrophages , 2000, The Journal of experimental medicine.

[10]  C. López-Otín,et al.  Molecular Cloning and Structural and Functional Characterization of Human Cathepsin F, a New Cysteine Proteinase of the Papain Family with a Long Propeptide Domain* , 1999, The Journal of Biological Chemistry.

[11]  R. Ménard,et al.  Full-length cDNA of human cathepsin F predicts the presence of a cystatin domain at the N-terminus of the cysteine protease zymogen. , 1999, Biochemical and biophysical research communications.

[12]  D. Turk,et al.  Crystal structure of MHC class II‐associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S , 1999, The EMBO journal.

[13]  B. Lenarčič,et al.  Cathepsin S and Cruzipain Are Inhibited by Equistatin from Actinia equina , 1999, Biological chemistry.

[14]  H. Chapman,et al.  Human Cathepsin F , 1998, The Journal of Biological Chemistry.

[15]  B. Lenarčič,et al.  Thyropins--new structurally related proteinase inhibitors. , 1998, Biological chemistry.

[16]  W. Bode,et al.  HUMAN CATHEPSIN G , 1997 .

[17]  B. Lenarčič,et al.  Equistatin, a New Inhibitor of Cysteine Proteinases fromActinia equina, Is Structurally Related to Thyroglobulin Type-1 Domain* , 1997, The Journal of Biological Chemistry.

[18]  D. Turk,et al.  Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. , 1997, Biological chemistry.

[19]  V. Turk,et al.  Inhibition of bovine cathepsins L and S by stefins and cystatins. , 1996, Biological chemistry Hoppe-Seyler.

[20]  V. Turk,et al.  Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L , 1996, The Journal of experimental medicine.

[21]  M. Yamashita,et al.  A Novel Cysteine Protease Inhibitor of the Egg of Chum Salmon, Containing a Cysteine-rich Thyroglobulin-like Motif (*) , 1996, The Journal of Biological Chemistry.

[22]  T. Prasthofer,et al.  Characterization by spectroscopic, kinetic and equilibrium methods of the interaction between recombinant human cystatin A (stefin A) and cysteine proteinases. , 1995, The Biochemical journal.

[23]  D. Brömme,et al.  The baculovirus cysteine protease has a cathepsin B-like S2-subsite specificity. , 1995, Biological chemistry Hoppe-Seyler.

[24]  V. Turk,et al.  Identification of bovine stefin A, a novel protein inhibitor of cysteine proteinases , 1995, FEBS letters.

[25]  A. Davies.  Advances in the use of recombinant baculoviruses for the expression of heterologous proteins , 1995 .

[26]  V. Turk,et al.  Bovine stefin C, a new member of the stefin family. , 1993, Journal of Biological Chemistry.

[27]  M. Abrahamson,et al.  Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin. , 1992, The Biochemical journal.

[28]  Robert Huber,et al.  The refined 2.15 A X‐ray crystal structure of human liver cathepsin B: the structural basis for its specificity. , 1991, The EMBO journal.

[29]  A. Barrett,et al.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. , 1986, The Biochemical journal.

[30]  A. Barrett,et al.  Cystatin-like cysteine proteinase inhibitors from human liver. , 1984, The Biochemical journal.

[31]  J. Morrison,et al.  The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions , 1982 .

[32]  W. Greco,et al.  Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors. , 1979, The Journal of biological chemistry.